XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Segments and Disaggregated Revenue
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Segments and Disaggregated Revenue
13.

Segments and Disaggregated Revenue 



 

 

Construction

 


Medical

Development



Corporate and support

 


Consolidated

 


Six Months Ended June 30, 2023





















Revenue 

$ 10,600,990

$

$

$

$ 10,600,990

Cost of revenue



10,636,832











10,636,832

Operating expenses



176,987


897


1,217,376


7,439,825


8,835,085

Operating loss

(212,829 )

(897 )

(1,217,376 )

(7,439,825 )

(8,870,927 )

Other income (expense)

252,193




(475,046 )

18,816

(204,037 )

Income (loss) before income taxes

39,364

(897 )

(1,692,422 )

(7,421,009 )

(9,074,964 )

Net income attributable to non-controlling interest















Net income (loss) attributable to common stockholders of Safe & Green Holdings Corp.
$ 39,364
$ (897 )
$ (1,692,422 )
$ (7,421,009 )
$ (9,074,964 )























Total assets
$ 10,546,140

$ (897 )
$ (10,929,782 )
$ 6,383,877

$ 5,999,338

Depreciation and amortization
$
710,578

$

$

$

$ 710,578

Capital expenditures
$

$

$

$

$


























Construction




Medical




Development



Corporate and support




Consolidated



Six Months Ended June 30, 2022 

 



 







  





 






Revenue
$ 5,956,354

$ 10,203,215

$

$

$ 16,159,569

Cost of revenue



5,996,473


6,904,701








12,901,174

Operating expenses



207,646


27,065


597,856


3,334,792


4,167,359

Operating income (loss)

(247,765 )

3,271,449


(597,856 )

(3,334,792 )

(908,964 )

Other income (expense)

490,903



(121,569 )

23,762

393,096

Income (loss) before income taxes

 


243,138



3,271,449


(719,425

)

 

(3,311,030

)

 

(515,868 )

Net income attributable to non-controlling interest

 


 



1,616,669








1,616,669

Net income (loss) attributable to common stockholders of Safe & Green Holdings Corp.
$ 243,138
$ 1,654,780

$ (719,425 )
$ (3,311,030 )
$ (2,132,537 )























Total assets

$ 10,907,679

$ 2,322,505

$
8,902,271

$
10,007,048

$
32,139,503

Depreciation and amortization
$ 286,755

$ 26,820

$ 21,569

$

$ 335,144

Capital expenditures
$ 821,400

$ 28,621

$ 893,785

$ 8,193

$ 1,751,999

Inter-segment revenue elimination
$

$

$

$
$



 

 

Construction

 


Medical

Development



Corporate and support

 


Consolidated

 


Three Months Ended June 30, 2023





















Revenue 

$ 5,097,055

$

$

$

$ 5,097,055

Cost of revenue



5,063,425











5,063,425

Operating expenses



58,428





496,463


5,089,597


5,644,488

Operating loss

(24,798 )



(496,463 )

(5,089,597 )

(5,610,858 )

Other income (expense)

233,629




(187,749 )

9,454

55,334

Income (loss) before income taxes

208,831



(684,212 )

(5,080,143 )

(5,555,524 )

Net income attributable to non-controlling interest















Net income (loss) attributable to common stockholders of Safe & Green Holdings Corp.
$ 208,831
$
$ (684,212 )
$ (5,080,143 )
$ (5,555,524 )























Depreciation and amortization
$
562,070

$

$

$

$ 562,070

Capital expenditures
$

$

$

$

$


























Construction




Medical




Development



Corporate and support




Consolidated



Three Months Ended June 30, 2022 

 



 







  





 






Revenue
$ 4,237,585

$ 3,317,386

$

$

$ 7,554,971

Cost of revenue



4,275,759


2,507,252








6,783,011

Operating expenses



99,672


8,093


315,868


1,676,183


2,099,816

Operating income (loss)

(137,846 )

802,041


(315,868 )

(1,676,183 )

(1,327,856 )

Other income (expense)

372,223



(72,942 )

10,979


310,260

Income (loss) before income taxes

 


234,377

802,041


(388,810 )

 

(1,665,204 )

 

(1,017,596 )

Net income attributable to non-controlling interest

 


 



397,764








397,764

Net income (loss) attributable to common stockholders of Safe & Green Holdings Corp.
$ 234,377
$ 404,277

$ (388,810 )
$ (1,665,204 )
$ (1,415,360 )























Depreciation and amortization
$ 143,320

$ 13,410

$ 12,941

$

$ 169,671

Capital expenditures
$ 797,300

$ 28,621

$

$ 3,213

$ 829,134

Inter-segment revenue elimination
$

$

$

$

$